Chong Kun Dang Pharmaceutical

This study looked at how a tacrolimus tablet (TacroBell) works in 128 adults who received a kidney transplant. The goal was to measure drug levels in the blood and check how well patients tolerated the medicine. Tacrolimus is an immunosuppressant taken long-term to prevent organ …

This study tested a new medicine called CertiroBell® against a standard anti-rejection drug (mycophenolate mofetil) in 150 adults who received a liver transplant from a living donor. The goal was to see if CertiroBell® works as well or better at preventing organ rejection, graft …

This early-stage study tested a new combination pill (CKD-383) for type 2 diabetes in 30 healthy adults. The goal was to see how the body absorbs and processes the drug and to check for any safety issues. Participants took the new pill and also the separate ingredients on differe…

This study tested a new combination drug called CKD-383 in 31 healthy adults. The goal was to see how the body absorbs and processes the drug compared to taking three separate diabetes medications. This early-stage research helps understand safety and drug levels, not to treat th…

This early-stage study tested a new drug called CKD-846 in 31 healthy men to see how the body processes it and if it is safe. The drug is being developed for benign prostate hypertrophy (BPH), a common condition where the prostate gland enlarges. The study did not treat any disea…